SIRPA Specific Neutra™ Antibody (V3S-1023-FY133), Human IgG (CAT#: V3S-1023-FY133)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This is a human antibody that specifically targets human SIRPA. The clone is effective against both human and cynomolgus monkey SIRPα. It strongly inhibits the interaction between SIRPα and CD47, with an IC₅₀ of approximately 0.3 nM.
Clonality Monoclonal
Host Species Human
Target Species Human, Monkey
Cross Reactivity Human SIRPα v1 and v2 alleles and cynomolgus SIRPα
IC50 0.3 nM
EC50 0.3 nM
Affinity KD = 1 pM (human)
KD = 100 pM (cynomolgus)
Isotype Human IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; Block

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target SIRPA
Alternative Name BIT; MFR; P84; SIRP; MYD-1; SHPS1; CD172A; PTPNS1; tyrosine-protein phosphatase non-receptor type substrate 1; CD172 antigen-like family member A; brain-immunoglobulin-like molecule with tyrosine-based activation motifs; inhibitory receptor SHPS-1; macrophage fusion receptor; myd-1 antigen; tyrosine phosphatase SHP substrate 1
Gene ID 140885
UniProt P78324
Research Area Neuroscience
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry